Do you feel the ACR RA guidelines are sufficient? #RheumJC to explore this issue in Thursday's Twitter chat.
Christopher Collins M.D.
Secukinumab will be the focus of the next Rheumatology Journal Club (#RheumJC) Twitter chat at 4 p.m. and 10 p.m. EST on May 5.
A study in Rheumatology shows that joint damage in rheumatoid arthritis is down by about 50 percent in 25 years, which aligns with what physicians are seeing in practice - including a reduction in joint replacement surgery referrals.